bpc-157 human randomized controlled trials Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157 as an Investigational Peptide

Three-dimensional attachment morphometry and volumetric changes of masticatory muscles after free fibular flap reconstruction of the mandibular condyle

Each has its own evidence base and safety boundary

AAPM is no longer just saying that BPC-157 has promising animal data

doi: 10.1006/excr.1994.1352

Testimonials from past patients are available on the clinics official website

For evaluating its future clinical use as a therapeutic drug and follow-up clinical trials, the present study was undertaken to evaluate the pharmacokinetics, tissue distribution, metabolism, and drug excretion of BPC157 in Sprague-Dawley (SD) rats and beagle dogs as well as in associated in vitro studies